Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis.
Horiuchi T, Kiyohara C, Tsukamoto H, Sawabe T, Furugo I, Yoshizawa S, Ueda A, Tada Y, Nakamura T, Kimoto Y, Mitoma H, Harashima S, Yoshizawa S, Shimoda T, Okamura S, Nagasawa K, Harada M. Horiuchi T, et al. Among authors: yoshizawa s. Ann Rheum Dis. 2007 Mar;66(3):320-4. doi: 10.1136/ard.2006.058917. Epub 2006 Oct 6. Ann Rheum Dis. 2007. PMID: 17028114 Free PMC article. Review.
Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.
Kimoto Y, Horiuchi T, Tsukamoto H, Kiyohara C, Mitoma H, Uchino A, Furugo I, Yoshizawa S, Ueda A, Harashima S, Sawabe T, Tahira T, Hayashi K, Yoshizawa S, Shimoda T, Akashi K, Harada M. Kimoto Y, et al. Among authors: yoshizawa s. Rheumatology (Oxford). 2010 Jul;49(7):1346-53. doi: 10.1093/rheumatology/keq050. Epub 2010 Apr 5. Rheumatology (Oxford). 2010. PMID: 20371502
Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial.
Ishiguro N, Yamamoto K, Katayama K, Kondo M, Sumida T, Mimori T, Soen S, Nagai K, Yamaguchi T, Hara M; Iguratimod-Clinical Study Group. Ishiguro N, et al. Mod Rheumatol. 2013 May;23(3):430-9. doi: 10.1007/s10165-012-0724-8. Epub 2012 Jul 26. Mod Rheumatol. 2013. PMID: 22833377 Clinical Trial.
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: yoshizawa s. Mod Rheumatol. 2013 Apr 8. doi: 10.1007/s10165-013-0878-z. Online ahead of print. Mod Rheumatol. 2013. PMID: 23563508
Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.
Nakashima Y, Kondo M, Fukuda T, Harada H, Horiuchi T, Ishinishi T, Jojima H, Kuroda K, Miyahara H, Maekawa M, Nishizaka H, Nagamine R, Nakashima H, Otsuka T, Shono E, Suematsu E, Shimauchi T, Tsuru T, Wada K, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: yoshizawa s. Mod Rheumatol. 2014 Mar;24(2):258-64. doi: 10.3109/14397595.2013.854069. Mod Rheumatol. 2014. PMID: 24593201 Clinical Trial.
Impact of methotrexate dose on efficacy of adalimumab in Japanese patients with rheumatoid arthritis: Results from registered data analyses.
Nakashima Y, Miyahara H, Kondo M, Fukuda T, Harada H, Haraguchi A, Inoue Y, Ishinishi T, Maekawa M, Maeyama A, Nakashima M, Shono E, Suematsu E, Shimauchi T, Tsuru T, Tsukamoto H, Yoshizawa S, Yoshizawa S, Iwamoto Y. Nakashima Y, et al. Among authors: yoshizawa s. Mod Rheumatol. 2017 Jan;27(1):15-21. doi: 10.3109/14397595.2016.1170958. Epub 2016 May 4. Mod Rheumatol. 2017. PMID: 27142240
The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
Ono N, Inoue Y, Miyamura T, Ueda N, Nagano S, Inoue H, Oryoji K, Ota SI, Sawabe T, Yoshizawa S, Takeyama Y, Sadanaga Y, Takamori A, Kimoto Y, Miyake K, Horiuchi T, Nakashima H, Niiro H, Tada Y. Ono N, et al. Among authors: yoshizawa s. J Rheumatol. 2021 Mar;48(3):417-425. doi: 10.3899/jrheum.190373. Epub 2019 Sep 15. J Rheumatol. 2021. PMID: 31523048
545 results